Editorial: Host-microbe Interaction in SARS-CoV-2 Infection: Mechanism and Intervention

Kombe,Tengchuan Jin

DOI: https://doi.org/10.3389/fimmu.2023.1198868

IF: 7.3

2023-01-01

Frontiers in Immunology

Abstract:EDITORIAL article Front. Immunol., 18 April 2023Sec. Viral Immunology Volume 14 - 2023 | https://doi.org/10.3389/fimmu.2023.1198868

What problem does this paper attempt to address?

Overly Exuberant Innate Immune Response to SARS-CoV-2 Infection

Zhuo Zhou,Lili Ren,Li Zhang,Jiaxin Zhong,Yan Xiao,Zhilong Jia,Li Guo,Jing Yang,Chun Wang,Shuai Jiang,Donghong Yang,Guoliang Zhang,Hongru Li,Fuhui Chen,Yu Xu,Mingwei Chen,Zhancheng Gao,Jian Yang,Jie Dong,Bo Liu,Xiannian Zhang,Weidong Wang,Kunlun He,Qi Jin,Mingkun Li,Jianwei Wang

DOI: https://doi.org/10.2139/ssrn.3551623

2020-01-01

SSRN Electronic Journal

Abstract:The outbreaks of 2019 novel coronavirus disease (COVID-19) caused by SARS-CoV-2 infection has posed a severe threat to global public health. It is unclear how the human immune system responds to the virus infection. Here, we profiled the immune transcriptome signatures by metatranscriptome sequencing for the bronchoalveolar lavage fluid from eight COVID-19 cases. The expression of the proinflammatory genes, especially chemokines, was markedly elevated in COVID-19 cases as compared to community-acquired pneumonia patients and healthy controls, suggesting that SARS-CoV-2 infection caused hypercytokinemia. Contrasting with SARS-CoV, which is thought to induce inadequate interferon (IFN) response, SARS-CoV-2 robustly triggered the expression of myriad IFN-inducible genes (ISGs). These ISGs exhibit immunopathogenic potentials, characterized by the overrepresentation of genes involved in inflammation. Collectively, we profiled the molecular signatures of the host response to SARS-CoV-2 infection, which could help to understand the disease pathogenesis and provided clues for tailored antiviral strategies, such as IFN therapy.
Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy

Qianqian Zhang,Rong Xiang,Shanshan Huo,Yunjiao Zhou,Shibo Jiang,Qiao Wang,Fei Yu

DOI: https://doi.org/10.1038/s41392-021-00653-w

IF: 39.3

2021-06-11

Signal Transduction and Targeted Therapy

Abstract:Abstract The pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has resulted in an unprecedented setback for global economy and health. SARS-CoV-2 has an exceptionally high level of transmissibility and extremely broad tissue tropism. However, the underlying molecular mechanism responsible for sustaining this degree of virulence remains largely unexplored. In this article, we review the current knowledge and crucial information about how SARS-CoV-2 attaches on the surface of host cells through a variety of receptors, such as ACE2, neuropilin-1, AXL, and antibody–FcγR complexes. We further explain how its spike (S) protein undergoes conformational transition from prefusion to postfusion with the help of proteases like furin, TMPRSS2, and cathepsins. We then review the ongoing experimental studies and clinical trials of antibodies, peptides, or small-molecule compounds with anti-SARS-CoV-2 activity, and discuss how these antiviral therapies targeting host–pathogen interaction could potentially suppress viral attachment, reduce the exposure of fusion peptide to curtail membrane fusion and block the formation of six-helix bundle (6-HB) fusion core. Finally, the specter of rapidly emerging SARS-CoV-2 variants deserves a serious review of broad-spectrum drugs or vaccines for long-term prevention and control of COVID-19 in the future.

biochemistry & molecular biology,cell biology
Editorial: Interferon Signaling in Viral Pathogenesis of Digestive and Respiratory Tract.

Pin Wan,Qiaoru Tan,Zhen Luo

DOI: https://doi.org/10.3389/fimmu.2023.1223080

IF: 7.3

2023-01-01

Frontiers in Immunology

Abstract:EDITORIAL article Front. Immunol., 14 June 2023Sec. Viral Immunology Volume 14 - 2023 | https://doi.org/10.3389/fimmu.2023.1223080
Editorial: Coronavirus Disease (COVID-19): Pathophysiology, Epidemiology, Clinical Management and Public Health Response

Denise L Doolan,Zisis Kozlakidis,Zhongheng Zhang,Slobodan Paessler,Longxiang Su,Yasuko Tsunetsugu Yokota,Tatsuo Shioda,Alexander Rodriguez-Palacios,Ata Murat Kaynar,Rukhsana Ahmed,Abdallah Samy,Hannah Bradby,Alexis M Kalergis,Mohan Jyoti Dutta,Michael Kogut,Shen-Ying Zhang

DOI: https://doi.org/10.3389/fpubh.2021.807159

IF: 5.2

2021-01-01

Frontiers in Public Health

Abstract:Citation: Doolan DL, Kozlakidis Z, Zhang Z, Paessler S, Su L, Yokota YT, Shioda T, Rodriguez-Palacios A, Kaynar AM, Ahmed R, Samy A, Bradby H, Kalergis AM, Dutta MJ, Kogut M and Zhang S-Y (2021) Editorial: Coronavirus Disease (COVID-19): Pathophysiology, Epidemiology, Clinical Management and Public Health Response. Front. Public Health 9:807159. doi: 10.3389/fpubh.2021.807159 Editorial: Coronavirus Disease (COVID-19): Pathophysiology, Epidemiology, Clinical Management and Public Health Response
Editorial: Molecular insight of chronic infections.

Honghua Hu,Leyi Wang,Qi Zhao

DOI: https://doi.org/10.3389/fmicb.2022.1112456

IF: 5.2

2023-01-01

Frontiers in Microbiology

Abstract:EDITORIAL article Front. Microbiol., 04 January 2023Sec. Systems Microbiology Volume 13 - 2022 | https://doi.org/10.3389/fmicb.2022.1112456
Editorial: Immune regulation in sepsis

Huiling Zhang,Zuliang Jie,Peisong Gao,Yufeng Zhou,Duanwu Zhang

DOI: https://doi.org/10.3389/fimmu.2023.1298777

IF: 7.3

2023-01-01

Frontiers in Immunology

Abstract:EDITORIAL article Front. Immunol., 06 October 2023Sec. Inflammation Volume 14 - 2023 | https://doi.org/10.3389/fimmu.2023.1298777
Molecular recognition in the infection, replication, and transmission of COVID-19-causing SARS-CoV-2: an emerging interface of infectious disease, biological chemistry, and nanoscience

Prem Kumar,Jeladhara Sobhanan,Yuta Takano,Vasudevanpillai Biju

DOI: https://doi.org/10.1038/s41427-020-00275-8

IF: 10.761

2021-02-05

NPG Asia Materials

Abstract:Abstract A coronavirus (CoV) commonly known as SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) and causing COVID-19 (coronavirus disease of 2019) has become a pandemic following an outbreak in Wuhan. Although mutations in the SARS-CoV-2 spike glycoprotein (SGP) are obvious from comparative genome studies, the novel infectious nature of the virus, its new varients detected in the UK, and outside and recovery–death ratios of COVID-19 inspired us to review the mechanisms of the infection, replication, release, and transmission of progeny virions and the immune response in the host cell. In addition to the specificity of SARS-CoV-2 binding to angiotensin-converting enzyme 2 receptor and transmembrane protease serine 2, the varied symptoms and severity of the infection by the original and mutated forms of the virus suggest the significance of correlating the host innate and adaptive immunity with the binding of the virus to the mannose receptor via lipopolysaccharides (LPSs), toll-like receptors via LPS/proteins/RNA, and sialic acid (Sia) via hemagglutinin, or sugar-acid segments of glycans. HA-to-Sia binding is considered based on the innate Sia N-acetylneuraminic acid and the acquired Sia N-glycolylneuraminic acid in the epithelial cells and the sialidase/neuraminidase- or esterase-hydrolyzed release and transmission of CoVs. Furthermore, the cytokine storms common to aged humans infected with SARS-CoV-2 and aged macaques infected with SARS-CoV encourage us to articulate the mechanism by which the nuclear capsid protein and RNAs bypass the pattern recognition-induced secretion of interferons (IFNs), which stimulate IFN genes through the Janus-activated kinase-signal transducer and activator of a transcription pathway, leading to the secretion of antiviral proteins such as myxovirus resistance protein A/B. By considering the complexities of the structure, and the infectious nature of the virus and the structures and functions of the molecules involved in CoV infection, replication, and immune response, a new interface among virology, immunology, chemistry, imaging technology, drug delivery, and nanoscience is proposed and will be developed. This interface can be an essential platform for researchers, technologists, and physicians to collaborate and develop vaccines and medicines against COVID-19 and other pandemics in the future.

materials science, multidisciplinary
Editorial: New Advances in Obligate Intracellular Bacteria: Pathogenesis and Host Interactions

Jun Jiao,Jianfeng Wang,Jiaqi Fu

DOI: https://doi.org/10.3389/fcimb.2023.1338697

IF: 6.073

2023-01-01

Frontiers in Cellular and Infection Microbiology

Abstract:EDITORIAL article Front. Cell. Infect. Microbiol., 27 November 2023Sec. Bacteria and Host Volume 13 - 2023 | https://doi.org/10.3389/fcimb.2023.1338697
Editorial: Novel Insights into Insect Antiviral Immunity

Liang Jiang,Xiao-Qiang Yu,Luc Swevers

DOI: https://doi.org/10.3389/fimmu.2021.740989

IF: 7.3

2022-01-01

Frontiers in Immunology

Abstract:EDITORIAL article Front. Immunol., 10 January 2022Sec. Comparative Immunology Volume 12 - 2021 | https://doi.org/10.3389/fimmu.2021.740989
Editorial: the Relationship of Oral and Other Body Sites Microbiome in Human Diseases

Tiansong Xu,Ning Chen,Xuesong He,Feng Chen

DOI: https://doi.org/10.3389/fcimb.2023.1276473

IF: 6.073

2023-01-01

Frontiers in Cellular and Infection Microbiology

Abstract:EDITORIAL article Front. Cell. Infect. Microbiol., 23 August 2023Sec. Extra-intestinal Microbiome Volume 13 - 2023 | https://doi.org/10.3389/fcimb.2023.1276473
Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis

Jingjiao Li,Mingquan Guo,Xiaoxu Tian,Xin Wang,Xing Yang,Ping Wu,Chengrong Liu,Zixuan Xiao,Yafei Qu,Yue Yin,Chunxia Wang,Yucai Zhang,Zhaoqin Zhu,Zhenshan Liu,Chao Peng,Tongyu Zhu,Qiming Liang

DOI: https://doi.org/10.1016/j.medj.2020.07.002

2021-01-01

Med

Abstract:BACKGROUND: The ongoing coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a global public health concern due to relatively easy person-to-person transmission and the current lack of effective antiviral therapy. However, the exact molecular mechanisms of SARS-CoV-2 pathogenesis remain largely unknown.METHODS: Genome-wide screening was used to establish intraviral and viral-host interactomes. Quantitative proteomics was used to investigate the peripheral blood mononuclear cell (PBMC) proteome signature in COVID-19.FINDINGS: We elucidated 286 host proteins targeted by SARS-CoV-2 and >350 host proteins that are significantly perturbed in COVID-19-derived PBMCs. This signature in severe COVID-19 PBMCs reveals a significant upregulation of cellular proteins related to neutrophil activation and blood coagulation, as well as a downregulation of proteins mediating T cell receptor signaling. From the interactome, we further identified that non-structural protein 10 interacts with NF-κB-repressing factor (NKRF) to facilitate interleukin-8 (IL-8) induction, which potentially contributes to IL-8-mediated chemotaxis of neutrophils and the overexuberant host inflammatory response observed in COVID-19 patients.CONCLUSIONS: Our study not only presents a systematic examination of SARS-CoV-2-induced perturbation of host targets and cellular networks but it also reveals insights into the mechanisms by which SARS-CoV-2 triggers cytokine storms, representing a powerful resource in the pursuit of therapeutic interventions.FUNDING: National Key Research and Development Project of China, National Natural Science Foundation of China, National Science and Technology Major Project, Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, Shanghai Science and Technology Commission, Shanghai Municipal Health Commission, Shanghai Municipal Key Clinical Specialty, Innovative Research Team of High-level Local Universities in Shanghai, Interdisciplinary Program of Shanghai Jiao Tong University, SII Challenge Fund for COVID-19 Research, Chinese Academy of Sciences (CAS) Large Research Infrastructure of Maintenance and Remolding Project, and Chinese Academy of Sciences Key Technology Talent Program.
Editorial: Immunosenescence after sepsis

Xuan Lu,Yuan-Qiang Lu

DOI: https://doi.org/10.3389/fimmu.2023.1177148

IF: 7.3

2023-01-01

Frontiers in Immunology

Abstract:EDITORIAL article Front. Immunol., 10 March 2023Sec. Inflammation Volume 14 - 2023 | https://doi.org/10.3389/fimmu.2023.1177148
Innate and Adaptive Immunity during SARS-CoV-2 Infection: Biomolecular Cellular Markers and Mechanisms

Brent Brown,Vanshika Ojha,Ingo Fricke,Suhaila A Al-Sheboul,Chinua Imarogbe,Tanya Gravier,Michael Green,Lori Peterson,Ivoyl P. Koutsaroff,Ayça Demir,Jonatane Andrieu,Chiuan Yee Leow,Chiuan Herng Leow

DOI: https://doi.org/10.3390/vaccines11020408

2023-02-11

Vaccines

Abstract:The coronavirus 2019 (COVID-19) pandemic was caused by a positive sense single-stranded RNA (ssRNA) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, other human coronaviruses (hCoVs) exist. Historical pandemics include smallpox and influenza, with efficacious therapeutics utilized to reduce overall disease burden through effectively targeting a competent host immune system response. The immune system is composed of primary/secondary lymphoid structures with initially eight types of immune cell types, and many other subtypes, traversing cell membranes utilizing cell signaling cascades that contribute towards clearance of pathogenic proteins. Other proteins discussed include cluster of differentiation (CD) markers, major histocompatibility complexes (MHC), pleiotropic interleukins (IL), and chemokines (CXC). The historical concepts of host immunity are the innate and adaptive immune systems. The adaptive immune system is represented by T cells, B cells, and antibodies. The innate immune system is represented by macrophages, neutrophils, dendritic cells, and the complement system. Other viruses can affect and regulate cell cycle progression for example, in cancers that include human papillomavirus (HPV: cervical carcinoma), Epstein–Barr virus (EBV: lymphoma), Hepatitis B and C (HB/HC: hepatocellular carcinoma) and human T cell Leukemia Virus-1 (T cell leukemia). Bacterial infections also increase the risk of developing cancer (e.g., Helicobacter pylori). Viral and bacterial factors can cause both morbidity and mortality alongside being transmitted within clinical and community settings through affecting a host immune response. Therefore, it is appropriate to contextualize advances in single cell sequencing in conjunction with other laboratory techniques allowing insights into immune cell characterization. These developments offer improved clarity and understanding that overlap with autoimmune conditions that could be affected by innate B cells (B1+ or marginal zone cells) or adaptive T cell responses to SARS-CoV-2 infection and other pathologies. Thus, this review starts with an introduction into host respiratory infection before examining invaluable cellular messenger proteins and then individual immune cell markers.

immunology,medicine, research & experimental
Editorial: Advances in Molecular Biology, Pathogenesis, Diagnosis, Vaccines, and Treatment of Diseases Caused by Apicomplexan Parasites

Mingming Liu,Ningbo Xia,William Harold Witola,Kun Li

DOI: https://doi.org/10.3389/fcimb.2023.1205563

IF: 6.073

2023-01-01

Frontiers in Cellular and Infection Microbiology

Abstract:EDITORIAL article Front. Cell. Infect. Microbiol., 28 April 2023Sec. Parasite and Host Volume 13 - 2023 | https://doi.org/10.3389/fcimb.2023.1205563
Immune Response to SARS-CoV-2 and Mechanisms of Immunopathological Changes in COVID-19.

Ahmet Kursat Azkur,Mübeccel Akdis,Dilek Azkur,Milena Sokolowska,Willem van de Veen,Marie-Charlotte Brüggen,Liam O'Mahony,Yadong Gao,Kari Nadeau,Cezmi A Akdis

DOI: https://doi.org/10.1111/all.14364

IF: 12.4

2020-01-01

Allergy

Abstract:As a zoonotic disease that has already spread globally to several million human beings and possibly to domestic and wild animals, eradication of coronavirus disease 2019 (COVID-19) appears practically impossible. There is a pressing need to improve our understanding of the immunology of this disease to contain the pandemic by developing vaccines and medicines for the prevention and treatment of patients. In this review, we aim to improve our understanding on the immune response and immunopathological changes in patients linked to deteriorating clinical conditions such as cytokine storm, acute respiratory distress syndrome, autopsy findings and changes in acute-phase reactants, and serum biochemistry in COVID-19. Similar to many other viral infections, asymptomatic disease is present in a significant but currently unknown fraction of the affected individuals. In the majority of the patients, a 1-week, self-limiting viral respiratory disease typically occurs, which ends with the development of neutralizing antiviral T cell and antibody immunity. The IgM-, IgA-, and IgG-type virus-specific antibodies levels are important measurements to predict population immunity against this disease and whether cross-reactivity with other coronaviruses is taking place. High viral load during the first infection and repeated exposure to virus especially in healthcare workers can be an important factor for severity of disease. It should be noted that many aspects of severe patients are unique to COVID-19 and are rarely observed in other respiratory viral infections, such as severe lymphopenia and eosinopenia, extensive pneumonia and lung tissue damage, a cytokine storm leading to acute respiratory distress syndrome, and multiorgan failure. Lymphopenia causes a defect in antiviral and immune regulatory immunity. At the same time, a cytokine storm starts with extensive activation of cytokine-secreting cells with innate and adaptive immune mechanisms both of which contribute to a poor prognosis. Elevated levels of acute-phase reactants and lymphopenia are early predictors of high disease severity. Prevention of development to severe disease, cytokine storm, acute respiratory distress syndrome, and novel approaches to prevent their development will be main routes for future research areas. As we learn to live amidst the virus, understanding the immunology of the disease can assist in containing the pandemic and in developing vaccines and medicines to prevent and treat individual patients.
The interactions of SARS-CoV-2 with co-circulating pathogens: Epidemiological implications and current knowledge gaps

Anabelle Wong,Laura Barrero,Elizabeth Goult,Michael Briga,Sarah C. Kramer,Aleksandra Kovacevic,Lulla Opatowski,Matthieu Domenech de Cellès

DOI: https://doi.org/10.48550/arXiv.2205.07553

2022-05-16

Populations and Evolution

Abstract:Despite the availability of effective vaccines, the persistence of SARS-CoV-2 suggests that co-circulation with other pathogens and resulting multi-epidemics may become increasingly frequent. To better forecast and control the risk of such multi-epidemics, it is essential to elucidate the potential interactions of SARS-CoV-2 with other pathogens; these interactions, however, remain poorly defined. Here, we aimed to review the current body of evidence about SARS-CoV-2 interactions. To study pathogen interactions in a systematic way, we first developed a general framework to capture their major components: sign, strength, symmetry, duration, and mechanism. We then reviewed the experimental evidence from animal models about SARS-CoV-2 interactions. Of the 14 studies identified, 11 focused on the outcomes of co-infection with non-attenuated influenza A viruses and generally demonstrated that co-infection increased disease severity compared with either mono-infection. By contrast, the effect of co-infection on the viral load of either virus was variable and inconsistent across studies. Next, we reviewed the epidemiological evidence about SARS-CoV-2 interactions in human populations. Although numerous studies were identified, only few were specifically designed to infer interaction and many were prone to multiple biases, including confounding. Nevertheless, their results suggested that influenza and pneumococcal conjugate vaccinations were associated with reduced riskof SARS-CoV-2 infection. Finally, we formulated simple transmission models of SARS-CoV-2 co-circulation with a viral or a bacterial pathogen, showing how they can naturally incorporate the proposed framework. More generally, we argue that such models, when designed with an integrative and multidisciplinary perspective, will be invaluable tools to resolve the substantial uncertainties that remain about SARS-CoV-2 interactions.
Editorial: Immunology of tuberculosis

Zhidong Hu,Theolis Barbosa,Xiao‐Yong Fan

DOI: https://doi.org/10.3389/fitd.2023.1252114

2023-01-01

Frontiers in Tropical Diseases

Abstract:EDITORIAL article Front. Trop. Dis, 20 July 2023Sec. Major Tropical Diseases Volume 4 - 2023 | https://doi.org/10.3389/fitd.2023.1252114
Coronavirus biology and replication: implications for SARS-CoV-2

Philip V’kovski,Annika Kratzel,Silvio Steiner,Hanspeter Stalder,Volker Thiel

DOI: https://doi.org/10.1038/s41579-020-00468-6

IF: 88.1

2020-10-28

Nature Reviews Microbiology

Abstract:The SARS-CoV-2 pandemic and its unprecedented global societal and economic disruptive impact has marked the third zoonotic introduction of a highly pathogenic coronavirus into the human population. Although the previous coronavirus SARS-CoV and MERS-CoV epidemics raised awareness of the need for clinically available therapeutic or preventive interventions, to date, no treatments with proven efficacy are available. The development of effective intervention strategies relies on the knowledge of molecular and cellular mechanisms of coronavirus infections, which highlights the significance of studying virus–host interactions at the molecular level to identify targets for antiviral intervention and to elucidate critical viral and host determinants that are decisive for the development of severe disease. In this Review, we summarize the first discoveries that shape our current understanding of SARS-CoV-2 infection throughout the intracellular viral life cycle and relate that to our knowledge of coronavirus biology. The elucidation of similarities and differences between SARS-CoV-2 and other coronaviruses will support future preparedness and strategies to combat coronavirus infections.

microbiology
COVID-19: from immune response to clinical intervention.

Zheng-Yang Guo,Yan-Qing Tang,Zi-Bo Zhang,Juan Liu,Yu-Xin Zhuang,Ting Li

DOI: https://doi.org/10.1093/pcmedi/pbae015

2024-01-01

Precision Clinical Medicine

Abstract:The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has highlighted the pivotal role of the immune response in determining the progression and severity of viral infections. In this paper, we review the most recent studies on the complicated dynamics between SARS-CoV-2 and the host immune system, highlight the importance of understanding these dynamics in developing effective treatments and formulate potent management strategies for COVID-19. We describe the activation of the host's innate immunity and the subsequent adaptive immune response following infection with SARS-CoV-2. In addition, the review emphasizes the immune evasion strategies of the SARS-CoV-2, including inhibition of interferon production and induction of cytokine storms, along with the resulting clinical outcomes. Finally, we assess the efficacy of current treatment strategies, including antiviral drugs, monoclonal antibodies, and anti-inflammatory treatments, and discuss their role in providing immunity and preventing severe disease.
The trinity of COVID-19: immunity, inflammation and intervention

Matthew Zirui Tay,Chek Meng Poh,Laurent Rénia,Paul A. MacAry,Lisa F. P. Ng

DOI: https://doi.org/10.1038/s41577-020-0311-8

IF: 108.555

2020-04-28

Nature Reviews Immunology

Abstract:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic. Alongside investigations into the virology of SARS-CoV-2, understanding the fundamental physiological and immunological processes underlying the clinical manifestations of COVID-19 is vital for the identification and rational design of effective therapies. Here, we provide an overview of the pathophysiology of SARS-CoV-2 infection. We describe the interaction of SARS-CoV-2 with the immune system and the subsequent contribution of dysfunctional immune responses to disease progression. From nascent reports describing SARS-CoV-2, we make inferences on the basis of the parallel pathophysiological and immunological features of the other human coronaviruses targeting the lower respiratory tract — severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). Finally, we highlight the implications of these approaches for potential therapeutic interventions that target viral infection and/or immunoregulation. In the short time since SARS-CoV-2 infections emerged in humans, much has been learned about the immunological processes that underlie the clinical manifestation of COVID-19. Here, the authors provide an overview of the pathophysiology of SARS-CoV-2 infection and discuss potential therapeutic approaches.

immunology

Editorial: Host-microbe Interaction in SARS-CoV-2 Infection: Mechanism and Intervention

Overly Exuberant Innate Immune Response to SARS-CoV-2 Infection

Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy

Editorial: Interferon Signaling in Viral Pathogenesis of Digestive and Respiratory Tract.

Editorial: Coronavirus Disease (COVID-19): Pathophysiology, Epidemiology, Clinical Management and Public Health Response

Editorial: Molecular insight of chronic infections.

Editorial: Immune regulation in sepsis

Molecular recognition in the infection, replication, and transmission of COVID-19-causing SARS-CoV-2: an emerging interface of infectious disease, biological chemistry, and nanoscience

Editorial: New Advances in Obligate Intracellular Bacteria: Pathogenesis and Host Interactions

Editorial: Novel Insights into Insect Antiviral Immunity

Editorial: the Relationship of Oral and Other Body Sites Microbiome in Human Diseases

Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis

Editorial: Immunosenescence after sepsis

Innate and Adaptive Immunity during SARS-CoV-2 Infection: Biomolecular Cellular Markers and Mechanisms

Editorial: Advances in Molecular Biology, Pathogenesis, Diagnosis, Vaccines, and Treatment of Diseases Caused by Apicomplexan Parasites

Immune Response to SARS-CoV-2 and Mechanisms of Immunopathological Changes in COVID-19.

The interactions of SARS-CoV-2 with co-circulating pathogens: Epidemiological implications and current knowledge gaps

Editorial: Immunology of tuberculosis

Coronavirus biology and replication: implications for SARS-CoV-2

COVID-19: from immune response to clinical intervention.

The trinity of COVID-19: immunity, inflammation and intervention